CJC-1295 W/O DAC

99% Pure / Made in USA / Multidose

CJC-1295 (without Drug Affinity Complex) is a short-acting growth hormone-releasing hormone (GHRH) analog engineered for advanced research applications focused on natural growth hormone (GH) pulsatility and precise endocrine system modulation. Structurally designed to closely mimic endogenous GHRH, it enables controlled stimulation of pituitary GH release within tightly regulated research environments.

Mechanism of Action

CJC-1295 (No DAC) is studied for its ability to stimulate GH release in a pulsatile, physiologically aligned manner. Research suggests it influences:

• Short-acting GHRH receptor activation → triggers controlled GH pulses
• IGF-1 pathway signaling → supports downstream metabolic and regenerative processes
• Endocrine rhythm alignment → mimics natural GH secretion cycles
• Hormonal timing precision → allows for controlled frequency and response

This mechanism provides a refined model for studying how timing and frequency of hormone release impact biological systems.

Pulsatile GH Release & Hormone Timing

CJC-1295 (No DAC) is widely studied for its ability to replicate natural hormone rhythms. In controlled research models, it has demonstrated relevance in:

• Supporting physiologic GH pulse patterns
• Enhancing synchronization of endocrine rhythms
• Improving timing and responsiveness of hormone release
• Allowing precise control over GH signaling cycles

Endocrine Rhythm & Hormonal Balance

A defining advantage of CJC-1295 (No DAC) is its alignment with natural endocrine cycles. Research has explored its ability to:

• Support balanced and rhythmic hormone release patterns
• Enhance coordination within the hypothalamic-pituitary axis
• Improve adaptability of endocrine signaling systems
• Promote physiologically consistent hormone activity

Metabolic Efficiency & Signaling

CJC-1295 (No DAC) is also studied for its role in metabolic and energy-related pathways. Research suggests it may:

• Support metabolic efficiency through pulsatile hormone signaling
• Enhance coordination between energy utilization and hormone activity
• Influence nutrient partitioning in research models
• Contribute to balanced metabolic regulation

Recovery & Tissue-Support Pathways

Due to its controlled, pulse-based activity, CJC-1295 (No DAC) is frequently studied in recovery-focused research. Studies have examined its ability to:

• Support tissue repair and regeneration signaling
• Enhance recovery through physiologic GH release patterns
• Improve coordination between growth and repair processes
• Contribute to models of balanced recovery and regeneration

Key Research Focus Areas:

• Pulsatile growth hormone release and timing
• IGF-1 pathway activation and signaling
• Endocrine rhythm alignment and hormone cycling
• Recovery and tissue-support pathways
• Metabolic efficiency and GH-related processes

Quality & Compliance:

• ≥99% purity (HPLC & Mass Spectrometry verified)
• Manufactured in the USA
• Third-party tested by independent U.S. laboratories
• Sterile, lyophilized, multidose vial
• Produced to strict research-grade standards for consistency and reliability

Important Notice:

For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.

⸻